← back to search

Ly‐Mee Yu

Dartmouth–Hitchcock Medical Center · US
🔎 Find collaborators in Epidemiology · Microbiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Epidemiology · Microbiology
Research interest
Research interests include Pneumonia and Respiratory Infections, Bacterial Infections and Vaccines, Digital Mental Health Interventions, and Blood Pressure and Hypertension Studies.
h-index
73
citations
22,310
works
311
NIH funding
primary concept
Medicine
email

Recent publications

Optimising the monitoring and management of raised blood pressure including proteinuria testing during pregnancy: the BUMP research programme including 2 RCTs
2026cited by 0position: contributor
Optimising the monitoring and management of raised blood pressure including proteinuria testing during pregnancy: the BUMP research programme including 2 RCTs
Programme Grants for Applied Research 2026cited by 0position: contributordoi
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.
2025cited by 11position: contributordoi
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK
The Lancet Psychiatry 2025cited by 9position: middledoi
The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study.
2025cited by 3position: contributordoi
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration.
2025cited by 2position: contributordoi
Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.
2025cited by 1position: contributordoi
REMOVED: Ivermectin and COVID-19.
2025cited by 0position: contributordoi
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
2024cited by 30position: contributordoi
Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial.
2024cited by 26position: contributordoi
Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery
JAMA 2024cited by 21position: middledoi
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial.
2024cited by 20position: contributordoi
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.
2024cited by 19position: contributordoi
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
2024cited by 16position: contributordoi
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage
Trials 2024cited by 11position: middledoi
User engagement in clinical trials of digital mental health interventions: a systematic review.
2024cited by 9position: contributordoi
Nurse-delivered sleep restriction therapy in primary care for adults with insomnia disorder: a mixed-methods process evaluation.
2024cited by 5position: contributordoi
Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT.
2024cited by 4position: contributordoi
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial.
2024cited by 4position: contributordoi
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.
2024cited by 3position: contributordoi
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
2024cited by 3position: contributordoi
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage.
2024cited by 2position: contributordoi
Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial.
2024cited by 1position: contributordoi
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial.
2024cited by 1position: contributordoi
FOUND Trial: randomised controlled trial study protocol for case finding of obstructive sleep apnoea in primary care using a novel device.
2024cited by 1position: contributordoi
Culturally adapted digital intervention to reduce suicidal ideation for Syrian asylum seekers and refugees in the United Kingdom: A qualitative study (Preprint)
2024cited by 1position: contributordoi
Feasibility and Acceptability Study of a Culturally Adapted Web-Based Intervention to Reduce Suicidal Ideation for Syrian Asylum Seekers and Refugees in the United Kingdom: Protocol for a Mixed Methods Study.
2024cited by 0position: contributordoi
Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessment.
2024cited by 0position: contributordoi
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
2024cited by 0position: contributor
Feasibility and Acceptability Study of a Culturally Adapted Web-Based Intervention to Reduce Suicidal Ideation for Syrian Asylum Seekers and Refugees in the United Kingdom: Protocol for a Mixed Methods Study (Preprint)
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Christopher Butler · The George Institute for Global Health21 papers (2019–2025) · 21 papers (2019–2025)Daniel Freeman · Oxford Health NHS Foundation Trust12 papers (2019–2023)Gail Hayward · University of Oxford12 papers (2021–2025)Richard J McManus · University of Manchester11 papers (2020–2026)Duncan Richards · Royal College of General Practitioners10 papers (2021–2025)Paul Little · The London College10 papers (2020–2025)Nicola Williams · Royal Adelaide Hospital7 papers (2012–2024) · 6 papers (2021–2024) · 6 papers (2021–2024)Simon de Lusignan · UK Health Security Agency6 papers (2021–2022)Najib M Rahman · Xi'an Jiaotong University6 papers (2019–2025)Milensu Shanyinde · Public Library of Science6 papers (2019–2024)Andrew J. Pollard · Capgemini (United Kingdom)5 papers (2012–2024)Paul Leeson · John Radcliffe Hospital5 papers (2020–2026)Peter Bower · Manchester Academic Health Science Centre5 papers (2019–2024) · 5 papers (2021–2024) · 5 papers (2021–2024)Sadiya Shahid · University of Cambridge5 papers (2023–2024)Oliver Beuthin · University of Oxford5 papers (2023–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Epidemiology · Microbiology →